A Multi-country Study on the Prescription Patterns of Short Acting Beta-2 Agonist (SABA) and Its Potential Effects on Asthma Control: A Cross-Sectional Study on SABA Use in Asthma
CompletadoClinicalTrials.gov
ID: NCT03857178Tipo: OBSERVATIONALInicio: 29 de mar de 2019Fin estimado: 6 de may de 2020
The aim of the study is to describe the prescribing pattern of the different types of medications which are used to treat asthma, across multiple countries.
Elegibilidad
Sexo: ALL
Criterios de inclusión
Male and female patients ≥12 years-old
Documented diagnosis with Asthma as per medical records.
Have had ≥3 consultations with the HCP at study start date
After full explanation, a patient or legal guardian must have signed an informed consent document indicating that they understand the purpose of and the procedures required for the study and are willing to participate in the study.
Criterios de exclusión
Patient with a diagnosis of chronic obstructive pulmonary disease or other chronic respiratory disease different from Asthma.
An acute or chronic condition that, in the investigator's opinion, would limit the patient's ability to participate in this study
Ubicaciones
Research Site
San Salvador, Argentina
Patrocinadores
PrincipalAstraZeneca
Aviso: La información de este ensayo proviene de fuentes públicas y tiene carácter exclusivamente informativo. No constituye asesoramiento médico, regulatorio ni de ningún otro tipo. Las traducciones son automatizadas y no poseen validez oficial. Consultá siempre con un profesional de la salud. Ver Términos de Uso.
A Multi-country Study on the Prescription Patterns of Sho... | EligiMed